The present invention relates to hair care compositions comprising one or more actives useful for increasing hair diameter and methods of use thereof.
Many attributes contribute to the appearance of hair considered to be attractive. For instance, hair with a full and thick appearance is very desirable. In contrast, hair with a thin appearance is not as attractive, and can even lead to a perception that the thin-haired individual is older than their chronological age. Because of the foregoing problems associated with thin hair, many individuals expend great effort and time on grooming, yet still do not attain their desired hairstyle and appearance. This can lead to frustration and/or lack of confidence in his or her appearance. These problems can be experienced by both female and male consumers and at a variety of ages.
In view thereof, there is a need to provide consumers with a hair care composition that includes actives which increase hair diameter and therefore create a fuller and thicker appearance of the hair.
Provided is a method for increasing hair shaft diameter, the method including applying a hair care composition to a region of the hair, wherein the hair care composition includes from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.
Also provided is a hair care composition comprising from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.
These and other features, aspects, and advantages of the present invention will become evident to those skilled in the art from a reading of the present disclosure.
While the specification concludes with the claims particularly pointing and distinctly claiming the invention, it is believed that embodiments of the present invention will be better understood from the following description. In all embodiments of the present invention, all weight percentages are by weight of the total composition, unless specifically stated otherwise. All ratios are weight ratios, unless specifically stated otherwise. All ranges are inclusive and combinable. The number of significant digits conveys neither limitations on the indicated amounts nor on the accuracy of the measurements. All numerical amounts are understood to be modified by the word “about” unless otherwise specifically indicated. All measurements are understood to be made at 25° C. and at ambient conditions, where “ambient conditions” means conditions under about one atmosphere of pressure and at about 50% relative humidity. All such weights as they pertain to listed ingredients are based on the active level and do not include carriers or by-products that may be included in commercially available materials, unless otherwise specified.
As used herein, the term “hair care compositions” are compositions that are applied to the hair and/or the skin underneath the hair, including compositions used to treat or care for the hair. Products contemplated by the phrase “hair care composition” include, but are not limited to after-shave tonics and lotions, creams, emulsions, foams, hair conditioners (rinse-off and leave-on), hair colorants, hair tonics, liquids, lotions, mousses, propellant lotions, shampoos, shave gels, temporary beard hair dyes, and the like.
“Mammalian hair,” as referenced herein, includes hair on any part of the body of a mammal, and can include but is not limited to facial, cranial, or body hair. For instance, it can include hair on the scalp, head, neck, beard, moustache, eyebrows and sideburns hair.
I. Hair Care Compositions
According to an embodiment of the invention, the hair care composition may include one or more solvents, such as dipropyleneglycol, propylene glycol, butylene glycol, 1,4-butanediol, 3-allyloxy-1,2-propanediol, dipropylene glycol n-butyl ether, 1,2-hexanediol, dimethyl isosorbide, ethanol, 1,3-butanediol, 1,3-propanediol, 2,2′-thiodiethanol, and 1,6-hexanediol, or combinations thereof.
According to yet another embodiment, the hair care composition may further include one or more additional hair growth stimulating agents, such as those disclosed in U.S. Patent Application Publication No. 2010/0120871. Accordingly, non-limiting examples of additional hair growth stimulating agents include indole compounds, xanthine compounds, vitamin B3 compounds, panthenol compounds, and derivatives thereof.
A. Indole Compounds
The hair care compositions can further include an indole compound. As used herein, “indole compound” means one or more indoles, derivatives thereof, mixtures thereof, or salts thereof. Accordingly, the composition may include from about 0.1% to about 10% of the indole compound, from about 0.5% to about 5% of the indole compound, or from about 1% to about 2% of the indole compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition.
B. Xanthine Compounds
The hair care compositions can further include a xanthine compound. As used herein, “xanthine compound” means one or more xanthines, derivatives thereof, and mixtures thereof. Xanthine compounds that can be useful herein include, but are not limited to, caffeine, xanthine, 1-methylxanthine, theophylline, theobromine, derivatives thereof, and mixtures thereof. Accordingly, the composition may include from about 0.1% to about 10% of the xanthine compound, from about 0.5% to about 5% of the xanthine compound, or from about 1% to about 2% of the xanthine compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition. For example, the hair care composition may further include about 0.75% of caffeine.
In an embodiment, the amount of xanthine may be decreased to lessen potential white residue the may result from various formulations when the xanthine is present in higher amounts. In an embodiment, the hair care composition may comprise from about 0.01% to about 1% xanthine, alternative from about 0.01% to about 0.75% xanthine, alternatively from about 0.01% to about 0.5% xanthine, alternatively from about 0.01% to about 0.25% xanthine, and alternatively from about 0.01% to about 0.1% xanthine. In an embodiment, the hair care composition may have no xanthine.
C. Vitamin B3 Compounds
The hair care compositions can further include a vitamin B3 compound. As used herein, “vitamin B3 compound” means nicotinic acid, niacinamide, nicotinyl alcohol, derivatives thereof, and mixtures thereof. The vitamin B3 compound may be included as the substantially pure material, or as an extract obtained by suitable physical and/or chemical isolation from natural (e.g., plant) sources. Accordingly, the composition may include from about 0.1% to about 25% of the vitamin B3 compound; from about 0.5% to about 15% of the vitamin B3 compound; or from about 3.5% to about 7.5% of the vitamin B3 compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition. For example, the hair care composition may further include about 2.5% of vitamin B3.
D. Panthenol Compounds
The hair care compositions can further comprise a panthenol compound. As used herein, the term “panthenol compound” includes panthenol, one or more pantothenic acid derivatives, and mixtures thereof. Non-limiting examples of panthenol compounds include D-panthenol ([R]-2,4-dihydroxy-N-[3-hydroxypropyl)]-3,3-dimethylbutamide), D,L-panthenol, pantothenic acids and their salts (e.g., the calcium salt), panthenyl triacetate, royal jelly, panthetine, pantotheine, panthenyl ethyl ether, pangamic acid, pantoyl lactose, Vitamin B complex, or mixtures thereof. Accordingly, the composition may include from about 0.01% to about 5% of the panthenol compound; from about 0.03% to about 3% of the panthenol compound; from about 0.05% to about 2% of the panthenol compound; or from about 0.1% to about 1% of the panthenol compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition. For example, the hair care composition may further include about 0.15% of panthenol.
According to another aspect of the present invention, the hair care compositions may be free of oleanolic acid and/or biotinyl-GHK, which is contrary to that described in U.S. Patent Application No. 20060067905.
E. Hops
In an embodiment, the hair care composition may comprise hops. The hair care composition may comprise from about 0.01% about 5% hops, alternatively from about 0.01% to about 3% hops, alternatively from about 0.01% to about 1.5% hops, and alternatively from about 0.01% to about 1% hops. In an embodiment, the hair care composition may comprise no hops.
The hops may be extracted by different methods, including extraction in glycerin, extraction in water and denatured alcohol, or extraction in propylene glycol. In an embodiment, the hops is extracted in glycerin. In an embodiment, the hops extracted in glycerin may provide improved thickening as compared to other extraction methods. In an embodiment, the hops is of the Humulus Lupulus species.
F. Resorcinol
In an embodiment, the hair care composition may comprise resorcinol. The hair care composition may comprise from about 1% to about 14% resorcinol, alternatively from about 1% to about 13% resorcinol, alternatively from about 1% to about 11% resorcinol, alternatively from about 1% to about 9% resorcinol, alternatively from about 1% to about 8% resorcinol, alternatively from about 1% to about 4% resorcinol, and alternatively from about 1% to about 3% resorcinol.
In an embodiment, the resorcinol may be chlorinated. In an embodiment, the resorcinol may be non-chlorinated. In an embodiment, the chlorinated resorcinol may provide improved thickening as compared to non-chlorinated resorcinol.
G. Rheology Modifier
In one embodiment, the composition comprises a rheology modifier to increase the substantivity of the composition. Any suitable rheology modifier can be used. In an embodiment, the hair care composition may comprise from about 0.1% to about 10% of a rheology modifier, alternatively from about 0.5% to about 2.2% of a rheology modifier, alternatively from about 0.7% to about 2% of a rheology modifier, and alternatively from about 1% to about 1.5% of a rheology modifier. In an embodiment, the hair care composition may comprise from about 0.5% to about 2% of a rheology modifier, alternatively from about 0.5% to about 1.9% of a rheology modifier, alternatively from about 0.5% to about 1.7% of a rheology modifier, and alternatively from about 0.5% to about 1.4% of a rheology modifier. In an embodiment, the rheology modifier may be a polyacrylamide thickener.
Non-limiting examples of rheology modifiers include acrylamide/ammonium acrylate copolymer (and)polyisobutene (and) polysorbate 20; acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80; acrylates copolymer; acrylates/beheneth-25 methacrylate copolymer; acrylates/C10-C30 alkyl acrylate crosspolymer; acrylates/steareth-20 itaconate copolymer; ammonium polyacrylate/Isohexadecane/PEG-40 castor oil; C12-16 alkyl PEG-hydroxypropylhydroxyethyl ethylcellulose (HM-EHEC); carbomer; crosslinked polyvinylpyrrolidone (PVP); dibenzylidene sorbitol; hydroxyethyl ethylcellulose (EHEC); hydroxypropyl methylcellulose (HPMC); hydroxypropyl methylcellulose (HPMC); hydroxypropylcellulose (HPC); methylcellulose (MC); methylhydroxyethyl cellulose (MEHEC); PEG-150/decyl alcohol/SMDI copolymer; PEG-150/stearyl alcohol/SMDI copolymer; polyacrylamide/C13-14 isoparaffin/laureth-7; polyacrylate 13/polyisobutene/polysorbate 20; polyacrylate crosspolymer-6; polyamide-3; polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6; polyurethane-39; sodium acrylate/acryloyldimethyltaurate/dimethylacrylamide; crosspolymer (and) isohexadecane (and) polysorbate 60; sodium polyacrylate. Exemplary commercially-available rheology modifiers include ACULYN™ 28, Klucel M CS, Klucel H CS, Klucel G CS, SYLVACLEAR AF1900V, SYLVACLEAR PA1200V, Benecel E10M, Benecel K35M, Optasense RMC70, ACULYN™33, ACULYN™46, ACULYN™22, ACULYN™44, Carbopol Ultrez 20, Carbopol Ultrez 21, Carbopol Ultrez 10, Carbopol 1342, Sepigel™ 305, Simulgel™600, Sepimax Zen, and combinations thereof.
H. Carrier
According to another aspect of the present invention, the hair care compositions may further include at least about 20 weight percent of an aqueous carrier. According to one embodiment, the aqueous carrier may be prepared from demineralized or distilled water, for example. Other acceptable carriers that may be used in the aqueous carrier include, but are not limited to alcohol compounds, such as ethanol. According to one embodiment, the composition comprises alcohol, dipropylene glycol, and/or water.
The hair care compositions may have a pH ranging from about 3.0 to about 10, which may be measured by taking a direct pH measurement using a standard hydrogen electrode of the composition at 25° C. Accordingly, the pH of the hair care composition may be within the range from about 6 to about 9, for example.
I. Optional Ingredients
The compositions of the present invention can also additionally comprise any suitable optional ingredients as desired. For example, the composition can optionally include other active or inactive ingredients.
The compositions may include other common hair ingredients such as pyrithione zinc, minoxidil, silicones, glycerin, conditioning agents, and other suitable materials. The CTFA Cosmetic Ingredient Handbook, Tenth Edition (published by the Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, D.C.) (2004) (hereinafter “CTFA”), describes a wide variety of nonlimiting materials that can be added to the composition herein. Examples of these ingredient classes include, but are not limited to: abrasives, absorbents, aesthetic components such as fragrances, pigments, colorings/colorants, essential oils, skin sensates, astringents, etc. (e.g., clove oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, witch hazel distillate), anti-acne agents, anti-caking agents, antifoaming agents, antimicrobial agents (e.g., iodopropyl butylcarbamate), antioxidants, binders, biological additives, buffering agents, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers or materials, e.g., polymers, for aiding the film-forming properties and substantivity of the composition (e.g., copolymer of eicosene and vinyl pyrrolidone), opacifying agents, pH adjusters, propellants, reducing agents, sequestrants, rheology modifiers, hair conditioning agents, and surfactants.
In one embodiment, the composition comprises a rheology modifier to increase the substantivity of the composition, such that it does not drip undesirably onto other areas of the body, onto clothing, or onto home furnishings and may also perform as a film former. Any suitable rheology modifier can be used, for example, a cellulose-based rheology modifier, such as hydroxypropylmethylcellulose. Other non-limiting examples of rheology modifiers include acrylamide/ammonium acrylate copolymer (and)polyisobutene (and) polysorbate 20; acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80; acrylates copolymer; acrylates/beheneth-25 methacrylate copolymer; acrylates/C10-C30 alkyl acrylate crosspolymer; acrylates/steareth-20 itaconate copolymer; ammonium polyacrylate/Isohexadecane/PEG-40 castor oil; C12-16 alkyl PEG-2 hydroxypropylhydroxyethyl ethylcellulose (HM-EHEC); carbomer; crosslinked polyvinylpyrrolidone (PVP); dibenzylidene sorbitol; hydroxyethyl ethylcellulose (EHEC); hydroxypropyl methylcellulose (HPMC); hydroxypropyl methylcellulose (HPMC); hydroxypropylcellulose (HPC); methylcellulose (MC); methylhydroxyethyl cellulose (MEHEC); PEG-150/decyl alcohol/SMDI copolymer; PEG-150/stearyl alcohol/SMDI copolymer; polyacrylamide/C13-14 isoparaffin/laureth-7; polyacrylate 13/polyisobutene/polysorbate 20; polyacrylate crosspolymer-6; polyamide-3; polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6; polyurethane-39; sodium acrylate/acryloyldimethyltaurate/dimethylacrylamide; crosspolymer (and) isohexadecane (and) polysorbate 60; sodium polyacrylate. Exemplary commercially-available rheology modifiers include ACULYN™ 28, Klucel M CS, Klucel H CS, Klucel G CS, SYLVACLEAR AF1900V, SYLVACLEAR PA1200V, Benecel E10M, Benecel K35M, Optasense RMC70, ACULYN™33, ACULYN™46, ACULYN™22, ACULYN™44, Carbopol Ultrez 20, Carbopol Ultrez 21, Carbopol Ultrez 10, Carbopol 1342, Sepigel™ 305, Simulgel™600, Sepimax Zen, and combinations thereof.
The formulations of the present invention may be present in typical hair care compositions. They may be in the form of solutions, dispersion, emulsions, powders, talcs, encapsulated, spheres, spongers, solid dosage forms, foams, and other delivery mechanisms. The composition of the present invention may be hair tonics, leave-on hair products such as conditioners, treatment, and styling products, rinse-off hair products such as conditioners, shampoos, and treatment products; and any other form that may be applied to the hair and preferably applied to the scalp.
II. Method for Increasing Hair Shaft Diameter
The hair care composition described above may also be used in a method for increasing hair shaft diameter. The method may comprise applying the hair care composition to a region of the hair, wherein the hair care composition comprises from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.
The following are non-limiting examples of the present invention. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention, which would be recognized by one of ordinary skill in the art.
The data in Table 1 surprisingly showed that Hops Type 1 provided a measurable average thickness increase of the hair follicle when compared to Hops Type 2 and Type 3. The Example 1 formula was used to formulate each leg, substituting different types of hops.
In the examples, all concentrations are listed as weight percent, unless otherwise specified and may exclude minor materials such as diluents, filler, and so forth. The listed formulations, therefore, comprise the listed components and any minor materials associated with such components. As is apparent to one of ordinary skill in the art, the selection of these minors will vary depending on the physical and chemical characteristics of the particular ingredients selected to make the hair care compositions.
Measurement of Average Thickness Increase
The hair care composition may have a viscosity of from about 2,000 cps to about 20,000 cps, alternatively from about 10,000 cps to about 15,000 cps. The viscosity of the hair care composition may be determined by a cone and plate viscometer/rheometer which measures the viscous drag resulting from the sample material contained in the gap between a rotating cone and a stationary plate. The geometry of the cone and plate may be such that the entire sample is subjected to a uniform shear rate. A Brookfield Rheometer RS, with Cone C75-1, 26.7° C. temperature, 2.5 mL sample size, at 2 res/sec for 3 minutes may be used.
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
All documents cited in the Detailed Description of Embodiments of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Number | Name | Date | Kind |
---|---|---|---|
85311 | Kerr et al. | Dec 1868 | A |
665608 | Kotz | Jan 1901 | A |
724178 | Grant | Mar 1903 | A |
812241 | Shubert | Feb 1906 | A |
1064901 | Grosert | Jun 1913 | A |
1384671 | Murray | Jul 1921 | A |
1431943 | Gee | Oct 1922 | A |
1462400 | Warren | Jul 1923 | A |
1829021 | Sinclair | Oct 1931 | A |
1876033 | Starr | Sep 1932 | A |
1956769 | Maselli | May 1934 | A |
2031774 | Lewis et al. | Feb 1936 | A |
2118566 | Miles | May 1938 | A |
2171494 | Kyrides | Aug 1939 | A |
2293634 | Sluss | Aug 1942 | A |
2381048 | Arne | Aug 1945 | A |
2604102 | Krause | Jul 1952 | A |
2647490 | Twiet | Aug 1953 | A |
2794443 | Moore | Jun 1957 | A |
2809971 | Bernstein | Oct 1957 | A |
2826551 | Geen | Mar 1958 | A |
3101086 | Di Vito | Aug 1963 | A |
3204644 | Flora | Sep 1965 | A |
3236733 | Karsten | Feb 1966 | A |
3295537 | Young | Jan 1967 | A |
3457928 | Kurshenoff | Jul 1969 | A |
3463170 | McCullough | Aug 1969 | A |
3477447 | Eldredge | Nov 1969 | A |
3520311 | Iesersek et al. | Jul 1970 | A |
3575319 | Safianoff | Apr 1971 | A |
3658294 | Ewald | Apr 1972 | A |
3730182 | Boghosian | May 1973 | A |
3732591 | Gach | May 1973 | A |
3753196 | Kurtz et al. | Aug 1973 | A |
3755560 | Dickert et al. | Aug 1973 | A |
3761418 | Parran | Sep 1973 | A |
3960160 | Hogan | Jun 1976 | A |
3961635 | Miya | Jun 1976 | A |
3964500 | Drakoff | Jun 1976 | A |
4090647 | Dunning | May 1978 | A |
4121602 | Young | Oct 1978 | A |
4144325 | Voyt | Mar 1979 | A |
4152416 | Spitzer et al. | May 1979 | A |
4209027 | Morganroth | Jun 1980 | A |
4273144 | Morganroth | Jun 1981 | A |
4288433 | Koulbanis et al. | Sep 1981 | A |
4323683 | Bolich, Jr. et al. | Apr 1982 | A |
4324553 | Bugaut et al. | Apr 1982 | A |
4335103 | Barker et al. | Jun 1982 | A |
4345080 | Bolick, Jr. | Aug 1982 | A |
4354512 | Roppatte, Jr. | Oct 1982 | A |
4364837 | Pader | Dec 1982 | A |
4379753 | Bolich, Jr. | Apr 1983 | A |
4421769 | Dixon et al. | Dec 1983 | A |
4470982 | Winkler | Sep 1984 | A |
4495958 | Roeder | Jan 1985 | A |
4590687 | Caruso | May 1986 | A |
4602651 | Roppatte, Jr. | Jul 1986 | A |
4605026 | Nolin | Aug 1986 | A |
4671306 | Spector | Jun 1987 | A |
4733984 | Katsuda et al. | Mar 1988 | A |
4815637 | Nellis | Mar 1989 | A |
4872594 | Bloom | Oct 1989 | A |
4900545 | Wisotzki et al. | Feb 1990 | A |
4901891 | Goncalves | Feb 1990 | A |
4934388 | Gibbs | Jun 1990 | A |
4983383 | Maksimoski et al. | Jan 1991 | A |
5006004 | Dirksing et al. | Apr 1991 | A |
5041285 | Lundmark | Aug 1991 | A |
5043323 | Bombardelli et al. | Aug 1991 | A |
5054504 | Winrow | Oct 1991 | A |
5056480 | Murray, Sr. | Oct 1991 | A |
5059050 | Guglielmo | Oct 1991 | A |
5069898 | Goldberg | Dec 1991 | A |
5104646 | Bolich, Jr. et al. | Apr 1992 | A |
5106609 | Bolich, Jr. et al. | Apr 1992 | A |
5152305 | Niv | Oct 1992 | A |
5168833 | Spears | Dec 1992 | A |
5215759 | Mausner | Jun 1993 | A |
5227164 | Lundmark | Jul 1993 | A |
5227503 | Hagan et al. | Jul 1993 | A |
5261427 | Dolev | Nov 1993 | A |
5270035 | Chimento | Dec 1993 | A |
RE34584 | Grote et al. | Apr 1994 | E |
5301850 | Gueret | Apr 1994 | A |
5307964 | Toth | May 1994 | A |
5311887 | Ramsey | May 1994 | A |
5337764 | McKay | Aug 1994 | A |
5340570 | Wong et al. | Aug 1994 | A |
5364885 | Ahluwalia et al. | Nov 1994 | A |
5469286 | Nicole | Nov 1995 | A |
5470579 | Bonte et al. | Nov 1995 | A |
5502056 | Breitbarth | Mar 1996 | A |
5514374 | Bonte et al. | May 1996 | A |
5520918 | Smith | May 1996 | A |
D370783 | Korte | Jun 1996 | S |
5523078 | Baylin | Jun 1996 | A |
5555899 | Foreman | Sep 1996 | A |
5605257 | Beard | Feb 1997 | A |
5637606 | Matsumoto | Jun 1997 | A |
5641097 | Renault et al. | Jun 1997 | A |
5647606 | Jordan | Jul 1997 | A |
5649649 | Marelli | Jul 1997 | A |
5658575 | Ribier et al. | Aug 1997 | A |
5686082 | N'Guyen | Nov 1997 | A |
5686367 | Hayashi | Nov 1997 | A |
5687884 | Bodin et al. | Nov 1997 | A |
5702691 | Ichinose et al. | Dec 1997 | A |
D392887 | Wadsworth | Mar 1998 | S |
5738250 | Gillingham et al. | Apr 1998 | A |
5746348 | Bloom | May 1998 | A |
5750122 | Evans et al. | May 1998 | A |
5755241 | Cheung | May 1998 | A |
5765601 | Wells et al. | Jun 1998 | A |
5772077 | Tafur | Jun 1998 | A |
5803093 | Romano | Sep 1998 | A |
5848598 | Walz et al. | Dec 1998 | A |
5876703 | Ichinose et al. | Mar 1999 | A |
5937873 | Schlosser et al. | Aug 1999 | A |
5939082 | Oblong et al. | Aug 1999 | A |
5957342 | Gallien | Sep 1999 | A |
5958436 | Hahn et al. | Sep 1999 | A |
D415427 | Durliat | Oct 1999 | S |
5964226 | Sobel | Oct 1999 | A |
5965564 | Bianco et al. | Oct 1999 | A |
5975378 | Bayer | Nov 1999 | A |
5975381 | Revenu | Nov 1999 | A |
D419446 | Durliat | Jan 2000 | S |
6013270 | Hargraves et al. | Jan 2000 | A |
6013279 | Klett-Loch | Jan 2000 | A |
6015549 | Cowperthwaite et al. | Jan 2000 | A |
6035806 | Lorenzo | Mar 2000 | A |
D424938 | Wise | May 2000 | S |
6113926 | Soler et al. | Sep 2000 | A |
6120779 | Nayak et al. | Sep 2000 | A |
6158617 | Hershey et al. | Dec 2000 | A |
6161735 | Uchiyama et al. | Dec 2000 | A |
6192047 | Oota | Feb 2001 | B1 |
6202899 | Lasserre et al. | Mar 2001 | B1 |
6239170 | Ahluwalia et al. | May 2001 | B1 |
6260557 | Yarbrough | Jul 2001 | B1 |
6277360 | Carew et al. | Aug 2001 | B1 |
6286518 | Laporte | Sep 2001 | B1 |
6302607 | Burrowes et al. | Oct 2001 | B1 |
6318595 | Walters | Nov 2001 | B1 |
6322778 | Parr et al. | Nov 2001 | B1 |
6325070 | Tyroler et al. | Dec 2001 | B1 |
6334449 | Burrowes et al. | Jan 2002 | B1 |
6357449 | Chu et al. | Mar 2002 | B1 |
6369117 | Dubief et al. | Apr 2002 | B1 |
6414017 | Ahluwalia et al. | Jul 2002 | B2 |
6444647 | Robinson et al. | Sep 2002 | B1 |
6447762 | Casado Galcera | Sep 2002 | B1 |
6465421 | Duranton et al. | Oct 2002 | B1 |
D466017 | Kuo | Nov 2002 | S |
6495498 | Niemiec et al. | Dec 2002 | B2 |
6505983 | Seo | Jan 2003 | B1 |
6526987 | Gioia | Mar 2003 | B1 |
6539949 | Christensen | Apr 2003 | B2 |
6570010 | Ishida et al. | May 2003 | B2 |
6588964 | Au et al. | Jul 2003 | B1 |
6637440 | de Laforcade | Oct 2003 | B2 |
6649155 | Dunlop et al. | Nov 2003 | B1 |
6660047 | Stanley, III | Dec 2003 | B1 |
6675812 | Wiley | Jan 2004 | B1 |
6752157 | Lu Shao Hua | Jun 2004 | B2 |
6766806 | Thiebaut | Jul 2004 | B2 |
D499966 | Arminak | Dec 2004 | S |
6831107 | Dederen | Dec 2004 | B2 |
6858216 | Schulze zur Wiesche et al. | Feb 2005 | B2 |
6861061 | Maxon et al. | Mar 2005 | B2 |
6866167 | Bougamont | Mar 2005 | B2 |
6877924 | Mears et al. | Apr 2005 | B1 |
6908889 | Niemiec et al. | Jun 2005 | B2 |
6962158 | Anguelo | Nov 2005 | B1 |
6968849 | Vena et al. | Nov 2005 | B2 |
6976495 | Vena et al. | Dec 2005 | B2 |
6994846 | L'Alloret | Feb 2006 | B2 |
7000618 | Dovergne et al. | Feb 2006 | B2 |
7044137 | Glucksman et al. | May 2006 | B2 |
7067529 | Bolin et al. | Jun 2006 | B2 |
7077295 | Walker | Jul 2006 | B2 |
7081258 | Hwang et al. | Jul 2006 | B2 |
7081259 | Hong | Jul 2006 | B2 |
D534425 | Kuo | Jan 2007 | S |
7196055 | Gilchrest et al. | Mar 2007 | B2 |
7234239 | Saito et al. | Jun 2007 | B2 |
7243660 | Capristo | Jul 2007 | B2 |
7258852 | Maubru | Aug 2007 | B2 |
7278590 | Greer, Jr. et al. | Oct 2007 | B1 |
7285294 | Ishino et al. | Oct 2007 | B2 |
7294641 | Boulle et al. | Nov 2007 | B2 |
D574707 | Pietrowski et al. | Aug 2008 | S |
7409957 | Abergel | Aug 2008 | B2 |
7470657 | Guillou et al. | Dec 2008 | B2 |
7473435 | Koganov | Jan 2009 | B2 |
7514474 | Lipkin et al. | Apr 2009 | B1 |
7537791 | Koganov | May 2009 | B2 |
7550137 | Savaide et al. | Jun 2009 | B2 |
D605953 | Wang Treadway et al. | Dec 2009 | S |
7647933 | Morgenstern et al. | Jan 2010 | B2 |
7690535 | Law et al. | Apr 2010 | B2 |
7754775 | Mercier et al. | Jul 2010 | B2 |
D620807 | Wang Treadway et al. | Aug 2010 | S |
7790768 | Gan et al. | Sep 2010 | B2 |
7798154 | De Laforcade | Sep 2010 | B2 |
7814917 | Hurwitz | Oct 2010 | B2 |
7820636 | Okuda et al. | Oct 2010 | B2 |
7871599 | Khoshdel et al. | Jan 2011 | B2 |
D636261 | Michitsuji et al. | Apr 2011 | S |
7934512 | Spagnuolo | May 2011 | B2 |
7934626 | Choi et al. | May 2011 | B2 |
7934667 | Westrich | May 2011 | B2 |
7972075 | Tajima | Jul 2011 | B2 |
8047735 | Broadley et al. | Nov 2011 | B2 |
8109415 | Tu | Feb 2012 | B2 |
8118036 | Wang et al. | Feb 2012 | B2 |
8232317 | Gan et al. | Jul 2012 | B2 |
8316863 | De Laforcade et al. | Nov 2012 | B2 |
8336558 | Hurwitz | Dec 2012 | B2 |
8348897 | Shih et al. | Jan 2013 | B2 |
D675939 | Van Gogh | Feb 2013 | S |
D681876 | Still | May 2013 | S |
8475510 | Simon et al. | Jul 2013 | B2 |
D690876 | Murdock et al. | Oct 2013 | S |
8637569 | Birbara | Jan 2014 | B2 |
8784907 | Richards et al. | Jul 2014 | B2 |
9050407 | Shih et al. | Jun 2015 | B2 |
9242123 | Mahmud et al. | Jan 2016 | B2 |
9402792 | Mahmud et al. | Aug 2016 | B2 |
9554979 | Combs et al. | Jan 2017 | B2 |
9610233 | Mahmud et al. | Apr 2017 | B2 |
9649271 | Mahmud et al. | May 2017 | B2 |
9730953 | Birbara | Aug 2017 | B2 |
20010003583 | Montanari et al. | Jun 2001 | A1 |
20010012928 | Watabe | Aug 2001 | A1 |
20010018920 | De Laforcade | Sep 2001 | A1 |
20010031281 | kung et al. | Oct 2001 | A1 |
20010042553 | Duqueroie | Nov 2001 | A1 |
20020001605 | Carew et al. | Jan 2002 | A1 |
20020020421 | Vayrette | Feb 2002 | A1 |
20020034485 | Noser et al. | Mar 2002 | A1 |
20020056733 | Lasserre | May 2002 | A1 |
20020114770 | Bradley et al. | Aug 2002 | A1 |
20020139383 | Christensen | Oct 2002 | A1 |
20020158084 | Herring et al. | Oct 2002 | A1 |
20020183297 | Niazi | Dec 2002 | A1 |
20020197289 | Chevalier et al. | Dec 2002 | A1 |
20030003073 | Muller | Jan 2003 | A1 |
20030039619 | Bunger et al. | Feb 2003 | A1 |
20030049212 | Robinson et al. | Mar 2003 | A1 |
20030050201 | Guillou et al. | Mar 2003 | A1 |
20030059392 | L'Alloret | Mar 2003 | A1 |
20030068297 | Jain | Apr 2003 | A1 |
20030069618 | Smith, III et al. | Apr 2003 | A1 |
20030091521 | Midha et al. | May 2003 | A1 |
20030108577 | Lorant et al. | Jun 2003 | A1 |
20030108578 | Maubru | Jun 2003 | A1 |
20030157088 | Elliott et al. | Aug 2003 | A1 |
20030168476 | Sanchez | Sep 2003 | A1 |
20030175232 | Elliott et al. | Sep 2003 | A1 |
20030219392 | Kung et al. | Nov 2003 | A1 |
20040076654 | Vinson et al. | Apr 2004 | A1 |
20040131573 | Tang | Jul 2004 | A1 |
20040141935 | Styczynski et al. | Jul 2004 | A1 |
20040159326 | Fagerstrom et al. | Aug 2004 | A1 |
20040171693 | Gan et al. | Sep 2004 | A1 |
20040175347 | Bissett | Sep 2004 | A1 |
20040213859 | Zelickson | Oct 2004 | A1 |
20040214215 | Yu et al. | Oct 2004 | A1 |
20040223935 | Meunier | Nov 2004 | A1 |
20040241114 | Gupta | Dec 2004 | A1 |
20050000535 | Kim | Jan 2005 | A1 |
20050003024 | Oblong et al. | Jan 2005 | A1 |
20050031572 | Gallinat et al. | Feb 2005 | A1 |
20050053561 | Suginaka | Mar 2005 | A1 |
20050082315 | Hayakawa et al. | Apr 2005 | A1 |
20050092340 | Rijskamp | May 2005 | A1 |
20050100525 | Taguchi et al. | May 2005 | A1 |
20050153003 | Menon et al. | Jul 2005 | A1 |
20050186290 | Cals-Grierson | Aug 2005 | A1 |
20050191370 | De La Charriere et al. | Sep 2005 | A1 |
20050196418 | Yu et al. | Sep 2005 | A1 |
20050255059 | Oblong et al. | Nov 2005 | A1 |
20050255060 | Oblong et al. | Nov 2005 | A1 |
20050271692 | Gervasio-Nugent et al. | Dec 2005 | A1 |
20060008436 | Boulle et al. | Jan 2006 | A1 |
20060021628 | Mu et al. | Feb 2006 | A1 |
20060021629 | Mu et al. | Feb 2006 | A1 |
20060039878 | Khoshdel et al. | Feb 2006 | A1 |
20060045926 | Nimni et al. | Mar 2006 | A1 |
20060054178 | Sim | Mar 2006 | A1 |
20060067905 | Lintner et al. | Mar 2006 | A1 |
20060088478 | Andrews et al. | Apr 2006 | A1 |
20060088492 | Goddinger et al. | Apr 2006 | A1 |
20060099167 | Staudigel et al. | May 2006 | A1 |
20060133997 | Querleux et al. | Jun 2006 | A1 |
20060134053 | L'Alloret | Jun 2006 | A1 |
20060151539 | Tsubaki et al. | Jul 2006 | A1 |
20060266774 | Hierzer | Nov 2006 | A1 |
20060275237 | Bissett et al. | Dec 2006 | A1 |
20060275245 | Decoster et al. | Dec 2006 | A1 |
20070003509 | Farwick et al. | Jan 2007 | A1 |
20070009474 | Xie et al. | Jan 2007 | A1 |
20070068544 | Hackl et al. | Mar 2007 | A1 |
20070080172 | Tyrrell et al. | Apr 2007 | A1 |
20070095360 | Meinert et al. | May 2007 | A1 |
20070095721 | Davis et al. | May 2007 | A1 |
20070137669 | Hamilton et al. | Jun 2007 | A1 |
20070148102 | Kalbfleisch et al. | Jun 2007 | A1 |
20070160547 | Duffy et al. | Jul 2007 | A1 |
20070175491 | Graefe et al. | Aug 2007 | A1 |
20070183993 | Binder et al. | Aug 2007 | A1 |
20070193597 | Hurwitz | Aug 2007 | A1 |
20070299032 | Ehama et al. | Dec 2007 | A1 |
20080020004 | Birkel et al. | Jan 2008 | A1 |
20080041749 | McDermott | Feb 2008 | A1 |
20080057015 | Oblong et al. | Mar 2008 | A1 |
20080059313 | Oblong | Mar 2008 | A1 |
20080060665 | Umeno et al. | Mar 2008 | A1 |
20080064723 | Ideta et al. | Mar 2008 | A1 |
20080115796 | Montanari et al. | May 2008 | A1 |
20080206156 | Cronk | Aug 2008 | A1 |
20080206355 | Schwartz et al. | Aug 2008 | A1 |
20080207560 | Harada et al. | Aug 2008 | A1 |
20080213198 | Lintner et al. | Sep 2008 | A1 |
20080245380 | Ecker et al. | Oct 2008 | A1 |
20080245824 | Lyles | Oct 2008 | A1 |
20080249073 | Farwick et al. | Oct 2008 | A1 |
20080254055 | Oblong et al. | Oct 2008 | A1 |
20080317698 | Wells et al. | Dec 2008 | A1 |
20090000634 | Graefe et al. | Jan 2009 | A1 |
20090016970 | Cronk | Jan 2009 | A1 |
20090017147 | Lintner et al. | Jan 2009 | A1 |
20090039083 | Stull, Sr. et al. | Feb 2009 | A1 |
20090108023 | Houghton et al. | Apr 2009 | A1 |
20090208424 | Maibach et al. | Aug 2009 | A1 |
20090218418 | Sharief | Sep 2009 | A1 |
20090220445 | Iwata et al. | Sep 2009 | A1 |
20090220448 | Iwata et al. | Sep 2009 | A1 |
20090222350 | Iwata et al. | Sep 2009 | A1 |
20090264449 | Iwata | Oct 2009 | A1 |
20090274642 | Dawson, Jr. et al. | Nov 2009 | A1 |
20090275970 | Leibowitz | Nov 2009 | A1 |
20100012141 | Middlebrook | Jan 2010 | A1 |
20100018920 | Curran et al. | Jan 2010 | A1 |
20100083977 | Goddard-Clark et al. | Apr 2010 | A1 |
20100120871 | Dawson, Jr. et al. | May 2010 | A1 |
20100126522 | Fujinuma et al. | May 2010 | A1 |
20100137238 | Gan et al. | Jun 2010 | A1 |
20100161029 | Filippini et al. | Jun 2010 | A1 |
20100170917 | Ki | Jul 2010 | A1 |
20100218626 | Love et al. | Sep 2010 | A1 |
20100313905 | Fujinuma et al. | Dec 2010 | A1 |
20110005538 | Mercier et al. | Jan 2011 | A1 |
20110041863 | Roualdes | Feb 2011 | A1 |
20110064511 | Pires et al. | Mar 2011 | A1 |
20110110872 | Koganov et al. | May 2011 | A1 |
20110127293 | Pascatore | Jun 2011 | A1 |
20110232664 | Schreiber | Sep 2011 | A1 |
20110265805 | Laplante | Nov 2011 | A1 |
20120034173 | Batt et al. | Feb 2012 | A1 |
20120058060 | Noor et al. | Mar 2012 | A1 |
20120097180 | Harris et al. | Apr 2012 | A1 |
20120152270 | Hazan | Jun 2012 | A1 |
20120157478 | Dawson, Jr. et al. | Jun 2012 | A1 |
20120213842 | Birbara | Aug 2012 | A1 |
20120258185 | Oblong et al. | Oct 2012 | A1 |
20130133678 | Nakashima | May 2013 | A1 |
20130164390 | Dawson | Jun 2013 | A1 |
20130284195 | Murdock | Oct 2013 | A1 |
20130284196 | Murdock | Oct 2013 | A1 |
20130309332 | Fournial et al. | Nov 2013 | A1 |
20140093466 | Combs | Apr 2014 | A1 |
20140341832 | Mahmud et al. | Nov 2014 | A1 |
20140371690 | Sprada et al. | Dec 2014 | A1 |
20150314064 | Shih et al. | Nov 2015 | A1 |
20170296668 | Birbara | Oct 2017 | A1 |
Number | Date | Country |
---|---|---|
8802728 | Aug 2010 | BR |
0944695 | Apr 1974 | CA |
201261001 | Jun 2009 | CN |
1914822 | Jul 1980 | DE |
4121544 | Jan 1993 | DE |
19824454 | Dec 1999 | DE |
10128799 | Jan 2003 | DE |
10133196 | Jan 2003 | DE |
10140650 | Feb 2003 | DE |
10226468 | Jan 2004 | DE |
10319227 | Jun 2004 | DE |
102004039729 | Mar 2006 | DE |
102004041588 | Mar 2006 | DE |
202006002355 | Apr 2006 | DE |
20023828 | Aug 2006 | DE |
3259969 | Apr 1993 | EP |
0640333 | Jan 1995 | EP |
0943260 | Sep 1999 | EP |
1024091 | Aug 2000 | EP |
1097695 | Sep 2002 | EP |
1161934 | Apr 2004 | EP |
1430933 | Jun 2004 | EP |
1506767 | Feb 2005 | EP |
1308169 | Jun 2005 | EP |
1685826 | Aug 2006 | EP |
1700617 | Sep 2006 | EP |
1709956 | Oct 2006 | EP |
1771144 | Jul 2009 | EP |
1642565 | Jul 2010 | EP |
1676783 | Nov 2010 | EP |
2642941 | Feb 1981 | FR |
2580601 | Oct 1986 | FR |
2643375 | Jun 1991 | FR |
2751541 | Oct 1998 | FR |
2832062 | Feb 2004 | FR |
2930461 | Dec 2011 | FR |
849433 | Sep 1960 | GB |
2174356 | Nov 1986 | GB |
S6168406 | Apr 1986 | JP |
6117945 | Aug 1986 | JP |
63301810 | Dec 1988 | JP |
63310813 | Dec 1988 | JP |
H04189365 | Jul 1992 | JP |
H04193821 | Jul 1992 | JP |
H0597631 | Apr 1993 | JP |
H06211632 | Aug 1994 | JP |
H06234628 | Aug 1994 | JP |
H08040835 | Feb 1996 | JP |
H08073322 | Mar 1996 | JP |
2557390 | Nov 1996 | JP |
08291018 | Nov 1996 | JP |
10203924 | Jan 1997 | JP |
2583812 | Feb 1997 | JP |
09263534 | Oct 1997 | JP |
10053527 | Feb 1998 | JP |
10229978 | Sep 1998 | JP |
H1027439 | Oct 1998 | JP |
H10279437 | Oct 1998 | JP |
H1118821 | Jan 1999 | JP |
11130085 | May 1999 | JP |
H11130085 | May 1999 | JP |
11152213 | Jun 1999 | JP |
2000086449 | Mar 2000 | JP |
2000086510 | Mar 2000 | JP |
3078179 | Aug 2000 | JP |
2001058928 | Mar 2001 | JP |
2001145514 | May 2001 | JP |
3219881 | Oct 2001 | JP |
2001288043 | Oct 2001 | JP |
2002013569 | Jan 2002 | JP |
2002322094 | Nov 2002 | JP |
2002332218 | Nov 2002 | JP |
3400122 | Apr 2003 | JP |
3426436 | Jul 2003 | JP |
2004002264 | Jan 2004 | JP |
2004026709 | Jan 2004 | JP |
2004067573 | Mar 2004 | JP |
2004091354 | Mar 2004 | JP |
2004091370 | Mar 2004 | JP |
2004115465 | Apr 2004 | JP |
2004189644 | Jul 2004 | JP |
2004189645 | Jul 2004 | JP |
4133740 | May 2005 | JP |
2005225849 | Aug 2005 | JP |
2005272394 | Oct 2005 | JP |
2005296352 | Oct 2005 | JP |
3784472 | Jun 2006 | JP |
2006160608 | Jun 2006 | JP |
3820800 | Sep 2006 | JP |
2006232820 | Sep 2006 | JP |
3922311 | May 2007 | JP |
4173667 | Oct 2008 | JP |
2008230619 | Oct 2008 | JP |
4305756 | Jul 2009 | JP |
4469617 | May 2010 | JP |
4554805 | Sep 2010 | JP |
4574384 | Nov 2010 | JP |
5044069 | Oct 2012 | JP |
5483414 | May 2014 | JP |
5872752 | Mar 2016 | JP |
1606121 | Nov 1990 | SU |
WO8804931 | Jul 1988 | WO |
WO8910114 | Nov 1989 | WO |
WO9007290 | Jul 1990 | WO |
WO94014404 | Jul 1994 | WO |
WO9534271 | Dec 1995 | WO |
WO9606686 | Mar 1996 | WO |
WO9911224 | Mar 1999 | WO |
WO0048559 | Aug 2000 | WO |
WO0147482 | Jul 2001 | WO |
WO2006000257 | Jan 2006 | WO |
WO2006027279 | Mar 2006 | WO |
WO2006125442 | Nov 2006 | WO |
WO2007010478 | Jan 2007 | WO |
WO2008104655 | Sep 2008 | WO |
WO 2009090213 | Nov 2009 | WO |
WO2010138266 | Dec 2010 | WO |
WO2011073898 | Jun 2011 | WO |
WO2011156311 | Dec 2011 | WO |
WO2012038334 | Mar 2012 | WO |
Entry |
---|
PCT International Search Report and Written Opinion for PCT/US2014/037617 dated Oct. 6, 2014, 12 pages. |
“The treatment of 11 alopecia patients with resorcinol solution”, Japan, Dec. 31, 1975. |
“Effects of Zinc on the New Preparation Method of Hydroxy Double Salts”, Inorg. Chem. 1999, 38, 4211-4216. |
“Hair care composition and method for increasing diameter of hairs”, Frangrance Journal, Feb. 1992, p. 100. |
All final and non-final office actions for U.S. Appl. No. 11/897,084 (P&G Case 10557MC), See Pair. |
All final and non-final office actions for U.S. Appl. No. 12/393,311 (P&G Case AA752M), See Pair. |
All final and non-final office actions for U.S. Appl. No. 13/527,376 (P&G Case 10557M), See Pair. |
All final and non-final office actions for U.S. Appl. No. 13/633,623 (P&G Case 12268), See Pair. |
All final and non-final office actions for U.S. Appl. No. 13/723,865 (P&G Case 12319), See Pair. |
All final and non-final office actions for U.S. Appl. No. 13/871,123 (P&G Case 12457M), See Pair. |
All final and non-final office actions for U.S. Appl. No. 13/871,231 (P&G Case 12458), See Pair. |
All final and non-final office actions for U.S. Appl. No. 14/275,100 (P&G Case 12899), See Pair. |
All final and non-final office actions for U.S. Appl. No. 14/275,225 (P&G Case 12901), See Pair. |
All final and non-final office actions for U.S. Appl. No. 14/275,252 (P&G Case 12902), See Pair. |
All final and non-final office actions for U.S. Appl. No. 14/825,643 (P&G Case 12268D), See Pair. |
All final and non-final office actions for U.S. Appl. No. 15/195,063 (P&G Case 12899D), See Pair. |
All final and non-final office actions for U.S. Appl. No. 29/419,431 (P&G Case D2009), See Pair. |
All final and non-final office actions for U.S. Appl. No. 29/447,858 (P&G Case D2009D), See Pair. |
Anonymous: Plantur 39 Caffeine Tonic 200ml, XP002534819, Jul. 26, 2008, URL:http://www.askshop.co.uk/shopping/plantur-39-caffeine-tonic-200ml.html. |
Berger, R.S., et al., “The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.” British Journal of Dermatology, 2003, 149, pp. 354-362. |
Courtois, M. et al., “Aging and hair cycles,” British Journal of Dermatology, 1995, 132, pp. 86-93. |
de Lacharriere, O. et al., “Hair Diameter Diversity,” Arch Dematol., 2001, 137, pp. 641-646. |
Definition of “denatured alcohol”, http://worldnetweb.princeton.edu/peri/webwn?s=denatured%20alcohol, accessed Mar. 8, 2011. |
Factors influencing the skin pH, Aus: pH and Skin Care, www.abw.verlag.de, 2007, pp. 45-49. |
Final Report on the Safety Assessment of 4-Chloroesorincol, International Journal of Toxicology, Aug. 1996, pp. 284-294. |
Gottschalck, T.E., et al., “International Cosmetic Ingredient Dictionary and Handbook,” 2004, The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., XP002534910, ISBN 1-882621-34-4, 10th ed., vol. 2, p. 1307, col. 1. |
Hoffmann, R., “Trichoscan: Combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo,” Eur J. Drmatol 2001; 11, pp. 362-368. |
Lacarrubba, F. et al., “Videodermatoscopy Enhances Diagnostic Capability in Some Forms of Hair Loss,” Am J. Clin Dermatol, 2004, 5(3), pp. 205-208. |
M.P. Birch et al., “Hair density, hair diameter and the prevalence of female pattern loss,” British Journal of Dermatology 2001; 144, pp. 297-304. |
Olsen, EA et al., “Evaluation and treatment of male and female pattern hair loss,” J. Am Acad Dermatol, vol. 52, No. 2, Feb. 2005, p. 301-311. |
PCT International Search Report and Written Opinion for PCT/IB2009/050759 dated Feb. 25, 2009. |
PCT International Search Report and Written Opinion for PCT/IB2009/050760 dated Aug. 5, 2009. |
PCT International Search Report and Written Opinion for PCT/IB2009/050761 dated Feb. 25, 2009. |
PCT International Search Report and Written Opinion for PCT/IB2009/050762 dated Feb. 25, 2009. |
PCT International Search Report and Written Opinion for PCT/US2012/058560 dated Mar. 11, 2013. |
PCT International Search Report and Written Opinion for PCT/US2013/038311 dated Jul. 12, 2013. |
PCT International Search Report and Written Opinion for PCT/US2013/038312 dated Jul. 12, 2013. |
PCT Invitation to pay additional fees for PCT/US2007/019180 dated May 3, 2008. |
The Clinical Report Lansium Domesticum Jack V. Doku, vol. 23, No. 13, p. 133-146 (1989). |
W. Wenner, “The Reaction of L-Ascorbic and D-Iosascorbic Acid with Nicotinic Acid and Its Amide,” J. Organic Chemistry, vol. 14, pp. 22-26 (1949). |
Number | Date | Country | |
---|---|---|---|
20140341832 A1 | Nov 2014 | US |
Number | Date | Country | |
---|---|---|---|
61824196 | May 2013 | US |